NLS Pharmaceutics Ltd. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
NLS Pharmaceutics Ltd. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q2 2024.
  • NLS Pharmaceutics Ltd. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 986K shares, a 97.2% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 986K -34.7M -97.2% Jun 30, 2024 6-K 2024-10-18
Q4 2023 811K -31.6M -97.5% Dec 31, 2023 6-K 2024-10-18
Q2 2023 35.7M +17.9M +101% Jun 30, 2023 6-K 2023-12-06
Q4 2022 32.4M +16.2M +99.9% Dec 31, 2022 20-F 2024-05-15
Q2 2022 17.8M +5.72M +47.4% Jun 30, 2022 6-K 2022-10-11
Q4 2021 16.2M +9.26M +133% Dec 31, 2021 20-F 2023-05-05
Q2 2021 12.1M Jun 30, 2021 6-K 2021-09-28
Q4 2020 6.96M 0 0% Dec 31, 2020 20-F 2022-03-24
Q4 2019 6.96M Dec 31, 2019 20-F 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.